Stem cell therapy for muscle and joint injuries
Part of Bones, joints & muscles, Injuries & trauma clinical trials.
This study tests a new therapy made from donor stem cells that may help repair damaged muscles, bones, tendons, and joints. It is for people whose injuries or degenerative conditions have not healed on their own.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a doctor-diagnosed muscle, bone, tendon, ligament, or joint injury or a degenerative condition (like arthritis).
- Your injury is not expected to heal on its own within 2 weeks without any aftereffects.
- You do not have serious health problems like advanced heart failure, uncontrolled high blood pressure, recent heart attack or stroke, or active cancer.
- You are not pregnant or breastfeeding, and you have no active serious infections like HIV, hepatitis B or C.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a stem cell product called StromaForte to see if it can reduce cardiovascular events like heart attacks in people with stable medical conditions. It may help if you have heart or blood vessel issues that have been stable for at least six months.
This study tests whether special stem cells (called UC-MSCs, derived from umbilical cord tissue) can reduce pain and improve function in people with moderate knee osteoarthritis. Researchers will inject these cells into your knee to see if they help repair damaged cartilage and reduce inflammation.
This early-phase study tests an injection of donor stem cells placed into the knee joint to help reduce symptoms of knee osteoarthritis. You may be eligible if you have long-lasting knee pain from mild-to-moderate arthritis and meet safety and imaging requirements.
This trial tests a combination of stem cells injected into the spinal fluid and a non-invasive spinal cord stimulation device to see if they can improve recovery after a spinal cord injury. It is for people who have had a single traumatic injury between neck and mid-back, 1 to 5 years ago, and are in stable health.
This trial tests whether a single infusion of stem cells from donated umbilical cord tissue can help calm inflammation in the brain after severe traumatic brain injury. It is for patients aged 18–50 who need brain pressure monitoring and are not responding to verbal commands 5 days after sedation is stopped.
This trial tests a new stem cell treatment (UC-MSCs) for knee osteoarthritis. It aims to see if this treatment is safe and can help reduce pain and improve knee function.
Hear when a new Musculoskeletal Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.